タイコバックの世界市場レポート 2025年：疫学、パイプライン分析、市場インサイト＆予測

タイコバックの市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7％で57億米ドルに成長します。この予測期間の成長は、屋外労働者の増加、ヘルスケア支出の増加、地域疾病対策への注目の高まり、健康保険適用率の上昇、ダニ媒介性脳炎（tbe）の罹患率の上昇などに起因しています。予測期間における主要動向としては、ワクチン製造の技術的進歩、新しいダニ媒介性脳炎ワクチンの導入、政府と製薬会社の協力、遺伝子研究の進歩、モニタリングの進歩、ワクチン接種後のケアなどが挙げられます。

ダニ媒介性疾患の流行の増加は、タイコバック市場の成長を促進すると予想されます。マダニ媒介性疾患は、マダニに咬まれることで感染し、細菌、ウイルス、寄生虫によって引き起こされるもので、気候変動、マダニの生息地の拡大、人体への曝露の増加、診断方法の改善などにより増加しています。タイコバックは、重症化する可能性のあるウイルス感染症であるダニ媒介性脳炎（TBE）に対する積極的な予防接種を提供することで、これらの病気と闘う上で重要な役割を果たしています。例えば、2024年2月、米国疾病予防管理センターは、米国におけるライム病の罹患率が以前に比べて68.8％増加したと報告し、マダニ媒介性疾患の負担が増大していることを浮き彫りにしました。このような罹患率の増加は、タイコバックのようなワクチンの需要を押し上げ、市場の成長を促進すると予想されます。

研究開発（R&D）活動の活発化は、タイコバック市場を推進する主要因です。研究開発活動は、新製品の創出、既存製品の強化、新たな世界的健康課題に対処するための技術開発を目的としています。医薬品セクタにおける研究開発への注力は、より優れた効能やダニ媒介性脳炎の新興株への対応能力など、ワクチン製剤を改善するイノベーションにつながっています。例えば、2024年7月、保健社会福祉省は、英国の製薬研究開発部門が2022年に113億米ドルを研究に費やしたと報告し、ダニ媒介性疾患のような健康の脅威に対処するための研究開発への投資が増加していることを強調しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 バイオ医薬品市場における製品特性

• 分子タイプ
• 投与経路（ROA）
• 作用機序（MOA）
• 安全性と有効性

第4章 市場動向と戦略

第5章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第6章 世界の成長分析と戦略分析フレームワーク

• 世界のタイコバック：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のタイコバック市場：成長率分析
• 世界のタイコバック市場の実績：規模と成長、2019～2024年
• 世界のタイコバック市場の予測：規模と成長、2024～2029年、2034年
• 世界のタイコバック：総潜在市場規模（TAM）

第7章 世界市場の価格分析と予測

第8章 市場セグメンテーション

• 世界のタイコバック市場：配合別、実績と予測、2019～2024年、2024～2029年、2034年
• 不活化ワクチン
• 生弱毒化ワクチン
• 世界のタイコバック市場：疾患別、実績と予測、2019～2024年、2024～2029年、2034年
• ダニ媒介性脳炎
• 日本脳炎
• 狂犬病脳炎
• 世界のタイコバック市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局

第9章 臨床適応症の世界市場疫学

• 薬剤の副作用
• 臨床適応症の発症率と有病率

第10章 地域別・国別分析

• 世界のタイコバック市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のタイコバック市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第11章 アジア太平洋市場

第12章 中国市場

第13章 インド市場

第14章 日本市場

第15章 オーストラリア市場

第16章 韓国市場

第17章 西欧市場

第18章 英国市場

第19章 ドイツ市場

第20章 フランス市場

第21章 東欧市場

第22章 北米市場

第23章 米国市場

第24章 カナダ市場

第25章 南米市場

第26章 中東市場

第27章 アフリカ市場

第28章 競合情勢と企業プロファイル

• タイコバック市場：競合情勢
• タイコバック市場：企業プロファイル
  • Pfizer Inc.

第29章 世界市場：パイプライン分析

第30章 世界の市場競合ベンチマーキングとダッシュボード

第31章 主要な合併と買収

第32章 最近の市場動向

第33章 市場の潜在力が高い国、戦略

• タイコバック市場、2029年：新たな機会を提供する国
• タイコバック市場、2029年：新たな機会を提供するセグメント
• タイコバック市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第34章 付録

TicoVac is a vaccine designed to protect against tick-borne encephalitis (TBE), a viral disease primarily transmitted through tick bites or, less frequently, through the consumption of unpasteurized dairy products from infected animals. TBE impacts the central nervous system and can cause severe neurological issues, such as meningitis and encephalitis. TicoVac works by stimulating the immune system to recognize and combat the tick-borne encephalitis virus (TBEV) if the body is exposed to it in the future.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types of ticoVac formulations are inactivated vaccines and live attenuated vaccines. Tick-borne encephalitis is a viral infection transmitted by infected ticks that affects the central nervous system, potentially causing severe neurological complications. The vaccine is also used for preventing Japanese encephalitis and rabies encephalitis and is distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

The ticovac market research report is one of a series of new reports from The Business Research Company that provides ticovac market statistics, including ticovac industry global market size, regional shares, competitors with a ticovac market share, detailed ticovac market segments, market trends and opportunities, and any further data you may need to thrive in the ticovac industry. This ticovac market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ticovac market size is expected to see strong growth in the next few years. It will grow to $5,700 million in 2029 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to increasing in outdoor workers, increasing healthcare expenditure, increasing focus on regional disease control, rising in health insurance coverage, rising incidence of tick-borne encephalitis (tbe) cases. Major trends in the forecast period include technological advancements in vaccine production, introduction of new tbe vaccines, collaborations between governments and pharmaceutical companies, advances in genetic research, advances in monitoring and post-vaccination care.

The rising prevalence of tick-borne diseases is expected to drive the growth of the ticovac market. Tick-borne diseases, which are transmitted through tick bites and caused by bacteria, viruses, or parasites, are increasing due to climate change, expanding tick habitats, greater human exposure, and improved diagnostic methods. Ticovac plays a crucial role in combating these diseases by providing active immunization against tick-borne encephalitis (TBE), a potentially severe viral infection. For example, in February 2024, the Centers for Disease Control and Prevention reported that the incidence of Lyme disease in the U.S. had risen by 68.8% compared to previous years, highlighting the growing burden of tick-borne diseases. This rise in incidence is expected to boost the demand for vaccines such as ticovac, driving market growth.

The increasing research and development (R&D) activities are key factor propelling the ticovac market. R&D efforts are aimed at creating new products, enhancing existing ones, and developing technologies to address emerging global health challenges. The focus on R&D in the pharmaceutical sector has led to innovations that improve vaccine formulations, including better efficacy and the ability to address emerging strains of tick-borne encephalitis. For example, in July 2024, the Department of Health and Social Care reported that the UK's pharmaceutical R&D sector spent $11.3 billion on research in 2022, emphasizing the increasing investment in R&D to address health threats like tick-borne diseases.

A significant trend in the ticovac market is the development of innovative vaccine formulations, such as suspension liquids, which offer a competitive edge. Suspension liquid vaccines are designed for intramuscular injection and are available in different dosages for both adults and children. In September 2024, Pfizer launched Ticovac in Japan, marking the first vaccine of its kind in the country for the prevention of tick-borne encephalitis. This new formulation is expected to enhance the vaccine's accessibility and effectiveness, further driving market growth.

Key player operating in the ticovac market is Pfizer Inc.

Europe was the largest region in the ticovac market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ticovac market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ticovac market consists of sales of pediatric vaccines, cardiovascular and metabolic products, anti-infective medications and rare disease medications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ticovac Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ticovac market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ticovac ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ticovac market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Formulation: Inactivated Vaccines; Live Attenuated Vaccines
• 2) By Indication: Tick-Borne Encephalitis; Japanese Encephalitis; Rabies Encephalitis
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Companies Mentioned: Pfizer Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ticovac Market Characteristics

3. Ticovac Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Ticovac Market Trends And Strategies

5. Ticovac Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Ticovac Growth Analysis And Strategic Analysis Framework

• 6.1. Global Ticovac PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Ticovac Market Growth Rate Analysis
• 6.4. Global Ticovac Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Ticovac Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Ticovac Total Addressable Market (TAM)

7. Global Ticovac Market Pricing Analysis & Forecasts

8. Ticovac Market Segmentation

• 8.1. Global Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated Vaccines
• Live Attenuated Vaccines
• 8.2. Global Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tick-Borne Encephalitis
• Japanese Encephalitis
• Rabies Encephalitis
• 8.3. Global Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

9. Global Ticovac Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Ticovac Market Regional And Country Analysis

• 10.1. Global Ticovac Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Ticovac Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Ticovac Market

• 11.1. Asia-Pacific Ticovac Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Ticovac Market

• 12.1. China Ticovac Market Overview
• 12.2. China Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Ticovac Market

• 13.1. India Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Ticovac Market

• 14.1. Japan Ticovac Market Overview
• 14.2. Japan Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Ticovac Market

• 15.1. Australia Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Ticovac Market

• 16.1. South Korea Ticovac Market Overview
• 16.2. South Korea Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Ticovac Market

• 17.1. Western Europe Ticovac Market Overview
• 17.2. Western Europe Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Ticovac Market

• 18.1. UK Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Ticovac Market

• 19.1. Germany Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Ticovac Market

• 20.1. France Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ticovac Market

• 21.1. Eastern Europe Ticovac Market Overview
• 21.2. Eastern Europe Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Ticovac Market

• 22.1. North America Ticovac Market Overview
• 22.2. North America Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Ticovac Market

• 23.1. USA Ticovac Market Overview
• 23.2. USA Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Ticovac Market

• 24.1. Canada Ticovac Market Overview
• 24.2. Canada Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Ticovac Market

• 25.1. South America Ticovac Market Overview
• 25.2. South America Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Ticovac Market

• 26.1. Middle East Ticovac Market Overview
• 26.2. Middle East Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Ticovac Market

• 27.1. Africa Ticovac Market Overview
• 27.2. Africa Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Ticovac Market Competitive Landscape And Company Profiles

• 28.1. Ticovac Market Competitive Landscape
• 28.2. Ticovac Market Company Profiles
  • 28.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Ticovac Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Ticovac Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Ticovac Market

32. Recent Developments In The Ticovac Market

33. Ticovac Market High Potential Countries, Segments and Strategies

• 33.1 Ticovac Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Ticovac Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Ticovac Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer